CELC
What one share of Celcuity holds
Services – Medical Laboratories
Inc., a Delaware corporation. We own various unregistered trademarks and service marks, including our corporate logo. Solely for convenience,
Celcuity’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$4.32 |
|---|---|
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$3.67 |
| Cash and investments | $3.72 |
| Debt | $0.00 |
| Book value | −$0.26 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | — | −$0.52 | $0.01 | −$0.46 | — | — |
| 2017 | — | −$0.84 | $0.03 | −$0.70 | — | $3.11 |
| 2018 | — | −$0.74 | $0.06 | −$0.66 | — | $2.49 |
| 2019 | — | −$0.72 | −$0.04 | −$0.55 | — | $1.88 |
| 2020 | — | −$0.92 | $0.01 | −$0.70 | — | $1.14 |
| 2021 | — | −$2.21 | $0.01 | −$1.52 | — | $4.61 |
| 2022 | — | −$2.62 | $0.01 | −$2.35 | — | $6.17 |
| 2023 | — | −$2.69 | $0.00 | −$2.28 | — | $5.48 |
| 2024 | — | −$2.83 | $0.01 | −$2.12 | — | $3.11 |
| 2025 | — | −$3.79 | $0.01 | −$3.28 | — | $2.08 |